Options to Minimize the Use of Central Lines: Midodrine, Peripheral Venous Lines, and Midline Catheters

Affiliations

Comment

Rania Farhat et al. Am J Respir Crit Care Med. 2021.

. 2021 Dec 15;204(12):1473-1475.

doi: 10.1164/rccm.202103-0685RR.

¹ Pulmonary and Critical Care Fellowship, Division of Pulmonary, Critical Care and Sleep Medicine, Saint Louis University, Saint Louis, Missouri.

No abstract available

Comment on

Safety of the Peripheral Administration of Vasopressor Agents.
Lewis T, Merchan C, Altshuler D, Papadopoulos J. Lewis T, et al. J Intensive Care Med. 2019 Jan;34(1):26-33. doi: 10.1177/0885066616686035. Epub 2017 Jan 11. J Intensive Care Med. 2019. PMID: 28073314
Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial.
Santer P, Anstey MH, Patrocínio MD, Wibrow B, Teja B, Shay D, Shaefi S, Parsons CS, Houle TT, Eikermann M; MIDAS Study Group. Santer P, et al. Intensive Care Med. 2020 Oct;46(10):1884-1893. doi: 10.1007/s00134-020-06216-x. Epub 2020 Sep 3. Intensive Care Med. 2020. PMID: 32885276 Free PMC article. Clinical Trial.
Safety and efficacy of vasopressor administration through midline catheters.
Prasanna N, Yamane D, Haridasa N, Davison D, Sparks A, Hawkins K. Prasanna N, et al. J Crit Care. 2021 Feb;61:1-4. doi: 10.1016/j.jcrc.2020.09.024. Epub 2020 Oct 2. J Crit Care. 2021. PMID: 33049486